QoL Conference Abstract and Publications

EORTC QOL PUBLICATIONS

Bottomley A, Pe M, Sloan J, Basch E, Bonnetain F, Calvert M, Campbell A, Cleeland C, Cocks K, Collette L, Dueck AC, Devlin N, Flechtner HH, Gotay C, Greimel E, Griebsch I, Groenvold M, Hamel JF, King M, Kluetz PG, Koller M, Malone DC, Martinelli F, Mitchell SA, Moinpour CM, Musoro J, O'Connor D, Oliver K, Piault-Louis E, Piccart M, Pimentel FL, Quinten C, Reijneveld JC, Schürmann C; Wilder Smith A, Soltys K, Taphoorn MJB, Velikova G, Coens C. Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a tart in setting international standards Lacent Oncol 17(11):e510-e514. doi: 10.1016/S1470-2045(16)30510-1, 2016

 

Reijneveld JC, Taphoorn MJ, Coens C, Bromberg JE, Mason WP, Hoang-Xuan K, Ryan G, Hassel MB, Enting RH, Brandes AA, Wick A, Chinot O, Reni M, Kantor G, Thiessen B, Klein M, Verger E, Borchers C, Hau P, Back M, Smits A, Golfinopoulos V, Gorlia T, Bottomley A, Stupp R, Baumert BG. Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study. Lancet Oncol. 2016 Sep 26. pii: S1470-2045(16)30305-9. doi: 10.1016/S1470-2045(16)30305-9

 

Ediebah DE, Reijneveld JC, Taphoorn MJ, Coens C, Zikos E, Aaronson NK, Heimans JJ, Bottomley A, Klein M. on behalf of the EORTC Quality of Life Department and Patient Reported Outcome and Behavioral Evidence (PROBE). Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients. Qual Life Res. 2016 Oct 15. [Epub ahead of print]

 

Quinten C, Coens C, Ghislain I, Zikos E, Sprangers MA, Ringash J, Martinelli F, Ediebah DE, Maringwa J, Reeve BB, Greimel E, King MT, Bjordal K, Flechtner HH, Schmucker-Von Koch J, Taphoorn MJ, Weis J, Wildiers H, Velikova G, Bottomley A. The effects of age on health-related quality of life in cancer populations: A pooled analysis of randomized controlled trials using the EORTC QLQ-C30 involving 6024 cancer patients. Eur J Cancer. 2015 Dec;51(18):2808-19. doi: 10.1016/j.ejca.2015.08.027. Epub 2015 Nov 19.

 

Zikos E, Coens C, Quinten C, Ediebah DE, Martinelli F, Ghislain I, King MT, Gotay C, Ringash J, Velikova G, Reeve BB, Greimel E, Cleeland CS, Flechtner H, Taphoorn MJ, Weis J, Schmucker-von Koch J, Sprangers MA, Bottomley A; EORTC PROBE. The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative. J Natl Cancer Inst. 2015 Dec 28;108(5). pii: djv391. doi: 10.1093/jnci/djv391. Print 2016 May.

 

Aaronson N, Ahmedzai S, Bullinger M, Crabeels D, Estapè J, Filiberti A, Flechtner H, Frick U, Hürny C, Kaasa S, Klee M, Mastilica M, Osoba D, Pfausler B, Razavi D, Rofe PBC, Schraub S, Sullivan M, Takeda F for the EORTC Study Group on Quality of Life. The EORTC Core Quality of Life questionnaires Interim results of an international field study. Effect of Cancer on Quality of Life. Chapter 14.

 

Dirven L, van de Poll-Franse LV, Aaronson NK, Reijneveld JC Controversies in the definition of cancer survivorship Lancet Oncol 16(6):610-2. doi: 10.1016/S1470-2045(15)70236-6, 2015.

 

Chu D, Popovic M, Chow E, Cella D, Beaumont JL, Lam H, Nguyen J, Giovanni JD, Pulenzas N, Bedard G, Bottomley A. Development, characteristics and validity of the EORTC QLQ-PR25 and the FACT-P for assessment of quality of life in prostate cancer patients. J Comp Eff Res. 2014 Sep; 3(5):523-31. doi: 10.2217/cer.14.41.

 

Winstanley JB, Young TE, Boyle FM, Bergenmar M, Bottomley A, Burmeister B, Campana LG, Garioch JJ, King M, Nikolic DV, van de Poll-Franse LV, Saw R, Thompson JF, White EG; on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group. Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma Module. Melanoma Res. 2014 Oct 16.

 

Yekaninejad MS, Pakpour AH, Tadakamadla J, Kumar S, Mosavi SH, Fridlund B, Bottomley A, Aaronson NK. Oral-health-related quality of life in patients with cancer: cultural adaptation and the psychometric testing of the Persian version of EORTC QLQ-OH17. Support Care Cancer. 2014 Oct 15.

 

Ediebah DE, Galindo-Garre F, Uitdehaag BMJ, Ringash J, Reijneveld JC, Dirven L, Zikos E, Coens C, Bent MJ van den, Bottomley A,  Taphoorn MJB. Joint modeling of longitudinal health-related quality of life data and survival. Qual Life Res. DOI 10.1007/s11136-014-0821-6, 2014.

 

Dirven L, Reijneveld JC, Taphoorn MJB. Health-related quality of life or quantity of life; a difficult trade-off in primary brain tumors? Sem Oncol 41, 541-552, 41(4):541-52. doi: 10.1053/j.seminoncol.2014.06.002, 2014.

 

Chow R, Lao N, Popovic M, Chow E, Cella D, Beaumont J, Lam H, Pulenzas N, Bedard G, Wong E, DeAngelis C, Bottomley A. Comparison of the EORTC QLQ-BN20 and the FACT-Br quality of life questionnaires for patients with primary brain cancers: a literature review. Support Care Cancer. 2014 Jul 12. PMID: 25015058

 

Chiu L, Chiu N, Chow E, Cella D, Beaumont JL, Lam H, Popovic M, Bedard G, Poon M, Wong E, Zeng L, Bottomley A. Comparison of Three Shortened Questionnaires for Assessment of Quality of Life in Advanced Cancer. J Palliat Med. 2014 Jun 12

 

Donneau AF, Mauer M, Coens C, Bottomley A, Albert A. Longitudinal quality of life data: a comparison of continuous and ordinal approaches. Qual Life Res. 2014 Jun 6. PMID: 24902940

 

Ediebah DE, Coens C, Zikos E, Quinten C, Ringash J, King MT, Schmucker von Koch J, Gotay C, Greimel E, Flechtner H, Weis J, Reeve BB, Smit EF, Taphoorn MJ, Bottomley A. Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial. Br J Cancer. 2014 May 13;110(10):2427-33. DOI: 10.1038/bjc.2014.208. Epub 2014 Apr 17.

 

Sodergren SC, White A, Efficace F, Sprangers M, Fitzsimmons D, Bottomley A, Johnson CD. On behalf of the EORTC Quality of Life Group. Systematic review of the side effects associated with tyrosine kinase inhibitors used in the treatment of gastrointestinal stromal tumours. Crit Rev Oncol Hematol. 2014 Jan 17. pii: S1040-8428(14)00012-2. doi: 10.1016/j.critrevonc.2014.01.002

 

Zikos E, Ghislain I, Coens C, Ediebah DE, Sloan E, Quinten C, Koller M, Van Meerbeeck J, Flechtner H, Stupp R, Pallis A, Czimbalmos A, Sprangers M, Bottomley A. Health-Related Quality of Life in Small-Cell Lung Cancer: A Systematic Review on Reporting of Methodological and Clinical Issues in Randomized Controlled Trials. The Lancet Oncology. 2014 Feb;15(2):e78-89. doi: 10.1016/S1470-2045(13)70493-5

 

Quinten C, Martinelli F, Coens C, Sprangers MA, Ringash J, Gotay C, Bjordal K, Greimel E, Reeve BB, Maringwa J, Ediebah DE, Zikos E, King M, Osoba D, Taphoorn MJ, Flechtner H, Schmucker-Von Koch J, Weis J, Bottomley A. On behalf of PROBE and the EORTC Clinical Groups. A global analysis of multi-trial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites. Journal of Clinical Oncology. 2014 Jan 15;120(2):302-11. doi: 10.1002/cncr.28382

 

Bottomley A, Tridello G, Coens C, Rolland F, Tesselaar MET, Leemans CR, Hupperets P, Licitra L,  Vermorken JB, Van Den Weyngaert D, Truc G, Barillot I, Lefebvre JL. An International Phase 3 Trial in Head and Neck Cancer: Quality of Life and Symptom Results. EORTC 24954 on Behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group. Cancer, 2014 Feb 1;120(3):390-8. doi: 10.1002/cncr.28392.

 

Habets EJJ, Taphoorn MJB, Nederend S, Klein M, Delgadillo D, Hoang- Xuan K, Bottomley A, Allgeier A, Seute T, Gijtenbeek AMM, de Gans J, Enting RH, Tijssen CC, van den Bent MJ, Reijneveld JC. Health-related quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors. Journal of Neuro-Oncology . 2014 Jan;116(1):161-8. doi: 10.1007/s11060-013-1278-0.

 

Yekaninejad MS, Ahmadzadeh A, Mosavi SH, Saffari M, Pakpour AH, Tolooei F, Chow E, Bottomley A. The reliability and validity of the Iranian version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with Bone Metastases: the EORTC QLQ-BM22. Expert Review of Pharmacoeconomics & Outcomes Research. 2014 Feb;14(1):147-56. doi: 10.1586/14737167.2014.864559.

 

Paradowski J, Tomaszewski KA, Bereza K, Tomaszewska IM, Walocha E, Paradowska D, Skotnicki P, Greimel ER, Bottomley A. Validation of the Polish version of the EORTC QLQ-OV28 module for the assessment of health-related quality of life in women with ovarian cancer. Expert Review of Pharmacoeconomics & Outcomes Research. 2014 Feb;14(1):157-63. doi: 10.1586/14737167.2014

 

Chiu L, Chow E, Chiu N, Zhang L, Bedard G, Fairchild A, Vassiliou V, Alm El-Din MA, Jesus-Garcia R, Forges F, Tseng LM, Hou MF, Chie WC, Satoh T, Ma BBY, Lam H, Bottomley A. Symptom clusters analysis in bone metastases patients using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Bone Metastases Module (EORTC QLQ-BM22). J Pain Manage. 2013. Volume 6, Number 4, P. 299

 

Armstrong TS, Wefel JS, Wang M, Gilbert MR, Won M, Bottomley A, Mendoza TR, Coens C, Werner-Wasik M, Brachman DG, Choucair AK, Mehta M. Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma. J Clin Oncol. 2013 Oct 7. PMID: 24101048

 

Püsküllüoğlu M, Tomaszewski KA, Bottomley A, Holden L, Tomaszewska IM, Głowacki R, Bereza K, Golec EB, Chow E, Krzemieniecki K. Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases. Qual Life Res. 2013 Aug 3.

 

Paradowska D, Tomaszewski KA, Bałajewicz-Nowak M, Bereza K, Tomaszewska IM, Paradowski J, Pityński K, Skotnicki P, Greimel ER, Bottomley A. Validation of the Polish version of the EORTC QLQ-CX24 module for the assessment of health-related quality of life in women with cervical cancer. Eur J Cancer Care (Engl). 2013 Aug 19. doi: 10.1111/ecc.12103

 

Wong E, Chow E, Zhang L, Bedard G, Lam K, Fairchild A, Vassiliou V, Alm El-Din MA, Jesus-Garcia R, Kumar A, Forges F, Tseng LM, Hou MF, Chie WC, Bottomley A. Factors Influencing Health Related Quality of Life in Cancer Patients with Bone Metastases. J Palliat Med. 2013 Aug; 16(8):915-21. doi: 10.1089/jpm.2012.0623

 

Huebner J, Rosé C, Geissler J, Gleiter CH, Prott FJ, Muenstedt K, Micke O, Muecke R, Buentzel J, Bottomley A, Hofheinz RD. Integrating cancer patients’ perspectives into treatment decisions and treatment evaluation using patient-reported outcomes – a concept paper. European Journal of Cancer Care. 2013 Jul 25. doi: 10.1111/ecc.12095

 

Senkus E, Gomez H, Dirix L, Jerusalem G, Murray E, Van Tienhoven G, Westenberg AH, Bottomley A, Rapion J, Bogaerts J, Di Leo A, Nešković-Konstantinović Z. Attitudes of young patients with breast cancer toward fertility loss related to adjuvant systemic therapies. EORTC study 10002 BIG 3-98† Psycho-Oncology. 2013. DOI: 10.1002/pon.3384

 

Lam K, Chow E, Zhang L, Wong E, Bedard G, Fairchild A, Vassiliou V, El-Din MA, Jesus-Garcia R, Kumar A, Forges F, Tseng LM, Hou MF, Chie WC, Bottomley A. Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatment. Support Care Cancer. 2013 Jun 19. PMID: 23775156

 

Dirven L, Reijneveld JC, Aaronson NK, Bottomley A, Uitdehaag B, Taphoorn M. Health-related Quality of Life in Patients with Brain Tumors: Limitations and Additional Outcome Measures. Curr Neurol Neurosci Rep. 2013. DOI 10.1007/s11910-013-0359-y. (7), 359, 2013

 

Cramarossa G, Chow E, Zhang L, Bedard G, Zeng L, Sahgal A, Vassiliou V, Satoh T, Foro P, Ma BB, Chie WC, Chen E, Lam H, Bottomley A. Predictive factors for overall quality of life in patients with advanced cancer. Support Care Cancer. 2013 Jan 22. PMID: 23338229. doi: 10.1007/s00520-013-1717-7.

 

Bottomley A, Kirby T, Bean J, Walker J. Moving the boundaries of international collaboration on clinical trials and QoL: Experiences in oncology and legislation within the European Parliament. Expert Review of Pharmacoeconomics & Outcomes Research.  2013 Feb;13(1):43-5. doi: 10.1586/erp.12.91. 

 

Ediebah, DE, Coens C, Maringwa JT, Quinten C, Zikos E, Ringash J, King M, Gotay C, Flechtner HH, Schmucker-Von Koch J, Weis J, Smit EF, Kohne CH and Bottomley A. on behalf of the Gastro-Intestinal Tract Cancer Cooperative Group, Lung Cancer Cooperative Group, Quality of Life Department and Patient Reported Outcome and Behavioural Evidence (PROBE). Effect of completion-time windows in the analysis of health-related quality of life outcomes in cancer patients. Ann Oncol. 2013 Jan;24(1):231-7. DOI: 10.1093/annonc/mds220. Epub 2012 Aug 30

 

 

EORTC QOL ABSTRACTS

 

Petersen MA et al. An initial international validation of the EORTC computer adaptive test (CAT) confirmed feasibility. 23rd Annual Conference for the International Society for Quality of Life Research, Copenhagen, Denmark, October 2016. Qual Life Res 25:1,80, 2016.

 

Arraras JI, Sztankay M, Wintner LM, Tomaszewski KM, Hofmeister D, Costantini A, Bredart A, Young T, Kuljanic K, Tomaszewska IM, Kontogianni M, Chie WC, Kuliś D, Greimel E. The EORTC communication-questionnaire: preliminary results of phase III and design of the validation study for the EORTC QLQ-COMU26. 23rd Annual Conference of the International Society for Quality of Life Research, Copenhagen, Denmark, October 2016. Qual Life Res 25:1, 2016.

 

Kuliś D, Bottomley A, Holzner B, Koller M, Swinburn P, Itani A, on behalf of the EORTC Quality of Life Group. Development of a Guidance on the Implementation and use of EORTC Instruments in Electronic Applications. ISPOR 19th Annual European Congress, Vienna, Austria, November 2016. Value in Health 19(7), November 2016.

 

Kuliś D, Bottomley A, Holzner B, Koller M, Swinburn P, Itani A, on behalf of the EORTC Quality of Life Group. Development of a Guidance on the Implementation and use of EORTC Instruments in Electronic Applications. ISPOR 19th Annual European Congress, Vienna, Austria, November 2016. Value in Health 19(7), November 2016.

 

Hamel JF, Pe M, Coens C, Martinelli F, Eggermont AM, Brandberg Y, Bottomley A; on behalf of the EORTC Quality of Life Group. Quality of life evolution for melanoma patients: a systematic review. 23rd Annual Conference of the International Society for Quality of Life Research, Copenhagen, Denmark, October 2016. Qual Life Res 25, 1, ab3023, 2016.

 

Hamel JF, Pe M, Coens C, Musoro J, Bottomley A; on behalf of the EORTC Quality of Life Group. An item response theory based method for detecting item level response-shift. 23rd Annual Conference of the International Society for Quality of Life Research, Copenhagen, Denmark, October 2016. Qual Life Res 25, 1, ab301.3, 2016.

 

Wintner LM, Sztankay M, Aaronson N, Bottomley A, Giesinger JM, Groenvold M, Petersen MA, van de Poll-Franse L, Velikova G, Verdonck-Leeuw I, Holzner B on behalf of the EORTC Quality of Life Group. A manual for the use of EORTC measures in daily clinical practice. 23rd Annual Conference of the International Society for Quality of Life Research, Copenhagen, Denmark, October 2016. Qual Life Res 25, 1, ab1061, 2016.

 

Kulis D, Sanchez Panos T, Whittaker C, Bottomley A, Greimel E, Bredart A, Koller M; on behalf of the EORTC Quality of Life Group. Challenges of the translation of the EORTC patient satisfaction questionnaires. 23rd Annual Conference of the International Society for Quality of Life Research, Copenhagen, Denmark, October 2016. Qual Life Res 25:1, 2016.

 

Kulis D, Whittaker C, Martinelli F, Sanchez Panos T, Bottomley A, Ruyskart P, Greimel E, Fitzsimmons D, Holzner B, Koller M; on behalf of the EORTC Quality of Life Group. Introducing the new EORTC Quality of Life Group Item Bank. 23rd Annual Conference of the International Society for Quality of Life Research, Copenhagen, Denmark, October 2016. Qual Life Res 25:1, 2016.

 

Ganesh V, Agarwal A, Popovic M, Cella D, McDonald R, Vuong S, Lam H, Rowbottom L, Chan S, Barakat T, DeAngelis C, Borean M, Chow E, Bottomley A. Comparison of the FACT-C, EORTC QLQ-CR38 and QLQ-CR29 quality of life: a review. 23rd Annual Conference of the International Society for Quality of Life Research, Copenhagen, Denmark, October 2016. Qual Life Res 25, 1, ab1011, 2016.

 

Koller M, Hjermstad M, Tomaszewski K, Harle A, Arraras J, Morag O, Pompili C, Ioannidis G, Georgiou L, Georgiou M, Navarra C, Chie WC, Johnson C, Himpel A, Schulz C, Hofmann HS, Kulis D, Bottomley A. Update of the EORTC questionnaire for assessing quality of life in patients with lung cancer – introducing the new EORTC QLQ-Lung Cancer 29 module. 23rd Annual Conference of the International Society for Quality of Life Research, Copenhagen, Denmark, October 2016. Qual Life Res 25:1, 2016.

 

Cocks K, Tolley C, Grant L, Wheelwright S, Tomaszewski K, Groenvold M, Bottomley A, Fitzsimmons D, Velikova G, Aaronson N, Johnson C. Evidence for the content validity of the EORTC QLQ-C30: Review of existing data. 23rd Annual Conference of the International Society for Quality of Life Research, Copenhagen, Denmark, October 2016. Qual Life Res 25, 1, ab303.4, 2016.

 

Musoro J, Coens C, Ediebah E, Eggermont A, Flechtner H, Greimel E, Groenvold M, King M, Piccart-Gebhart M, Reijneveld JC, Smit E, Sprangers M, Stupp R, Taphoorn M, Velikova G, Zikos E, Bottomley A. Empirical Evaluation of the Minimal Important Differences (MID) with the EORTC Quality of Life Group Measures: Embarking on a New Research Initiative on behalf of the EORTC Quality of Life Group and EORTC Quality of Life Department.. 23rd Annual Conference of the International Society for Quality of Life Research, Copenhagen, Denmark, October 2016. Qual Life Res 25, 1, ab202.5, p:43-44, 2016.

 

Coens C , Pe M, Sloan J, Basch E, Cleeland C, Cocks K, Collingridge D, Griebsch I, Koller M, Malone D, O’Connor D, Oliver K, PiaultLouis E, Piccart M, Pimentel F, Reijneveld JC, Schuermann C, Smith A, Velikova G, Bottomley A. Setting Standards for Analysis of Quality of Life Data for International Cancer Clinical Trials (SISAQOL Consortium). 23rd Annual Conference of the International Society for Quality of Life Research, Copenhagen, Denmark, October 2016. Qual Life Res 25, 1, ab101.5, p:23, 2016.

 

Pe M , Bottomley A, Bonnetain F, Campbell A, Collette L, Dueck A, Devlin N, Gotay C, Greimel E, Groenvold M, Hamel JF, King M, Martinelli F, Mitchell S, Moinpour C, Jammbe Musoro, Chantal Quinten, Melanie Calvert, Henning Flechtner, Martin Taphoorn, Coens C. A Systematic Review on the Choice and Implementation of Statistical Methods in Health-Related Quality of Life Data Analyses in Locally Advanced and Metastatic Breast Cancer Randomized Controlled Trials (SISAQOL Consortium). 23rd Annual Conference of the International Society for Quality of Life Research, Copenhagen, Denmark, October 2016. Qual Life Res 25, 1, ab101.4, p:22-23, 2016.

 

Bottomley A, Coens C, Musoro J, Martinelli F, Zikos E, Ghislain I, Hamel JF. A review of the quality of statistical methods employed for analyzing quality of life data in cancer RCTs. 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago (USA), June 2016. J Clin Oncol 34, 2016 (suppl; abstr 10058)

 

Koller M. Update of the EORTC questionnaire for assessing quality of life in patients with lung cancer? introducing the new EORTC QLQ-LC29. 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago (USA), June 2016.J Clin Oncol 34, 2016 (suppl; abstr e18096).

 

Wheelwright S, Hopkinson JB, Darlington A-S, Fitzsimmons DF, Fayers P, Balstad TR, Bredart A, Hammerlid E, Kaasa S, Nicolatou-Galitis O, Pinto M, Schmidt H, Solheim T, Strasser F, Tomaszewska IM15 and Johnson CD on behalf of the EORTC Quality of Life Group. Development of the EORTC QLQ-CAX24, a questionnaire for cancer patients with cachexia. 5th International Seminar of the PRC and EAPC RN, Leeds, UK, October 2015.

 

Groenvold M, Young T, Arraras JI, Holzner B, Aaronson NK, Petersen MA. Development of the EORTC CAT Social Function item bank. Invited plenary presentation. Annual Conference of the International Society for Quality of Life Research (ISOQOL), Vancouver, Canada, 23.10.15.

 

Kuijpers et al. Patients’ and health professionals’ understanding of and preferences for graphical presentation styles for individual quality of life scores obtained with the EORTC QLQ-C30 22nd Annual Conference for the International Society for Quality of Life Research, Vancouver, BC, Canada, 21-24 October 2015. Qual Life Res 25:119, 2015.

 

Petersen MA et al. The computer adaptive test (CAT) version of the EORTC QLQ-C30. 22nd Annual Conference for the International Society for Quality of Life Research, Vancouver, BC, Canada, 21-24 October 2015. Qual Life Res 24:1,54, 2015.

 

Giesinger JM et al.  Development of thresholds for clinical importance for four key domains of the EORTC QLQ-C30. 22nd Annual Conference for the International Society for Quality of Life Research, Vancouver, BC, Canada, 21-24 October 2015. Qual Life Res 24:1, 143, 2015.

 

Kemmler G et al. German utility weights for the EORTC QLQ-C30: first results of a general population survey using discrete choice experiments. 22nd Annual Conference for the International Society for Quality of Life Research, Vancouver, BC, Canada, 21-24 October 2015. Qual Life Res 24:1, 180, 2015.

 

Bella Vivat et al. Is there a relationship between spiritual wellbeing (SWB) and QOL? Findings from international validation of the EORTC QLQ-SWB32: 22nd Annual Conference for the International Society for Quality of Life Research, Vancouver, BC, Canada, 21-24 October 2015. Qual Life Res 24:1, 13, 2015.

 

Koller M, Hjermstad MJ, Tomaszewski K, Harle A,  Arraras JI, Morag O, Pompili C, Ioannidis G, Georgiou L, Georgiou M, Navarra C,  Chie WC, Johnson C, Himpel A, Schulz C, Hofmann HS, Kulis D, Bottomley A. Update of the EORTC questionnaire for assessing quality of life in lung cancer patients (EORTC QLQ-LC13). Oral presentation at the International Society for Quality of Life Research (ISOQOL) 22nd Annual Conference, Canada-2015 [206.1]. Qual Life Res 2015. 24:50-50.

 

Kuliś D, Whittaker C, Fiskovica E, Greimel E, Bottomley A, Koller M on behalf of the EORTC Quality of Life Group. Professional proofreading: a new step in the EORTC translation procedure to further improve output quality. 22nd Annual Conference for the International Society for Quality of Life Research, Vancouver, BC, Canada, 21-24 October 2015. Qual Life Res 24:1, 2015.

 

Kuliś D, Whittaker C, Fiskovica E, Greimel E, Bottomley A, Koller M on behalf of the EORTC Quality of Life Group. Why are two better than one: the added value of the second back translation in the EORTC translation procedure. 22nd Annual Conference for the International Society for Quality of Life Research, Vancouver, BC, Canada, 21-24 October 2015. Qual Life Res 24:1, 2015.

 

Zikos E, Ghislain I, Coens C, Quinten C, Balta V, Tryfonidis K, Piccart M, Zardavas D, Velikova G, Nagele E, Bjelic-Radisic V, Cardoso F, Sprangers M, Bottomley A. Health-related quality of life in advanced breast cancer: A systematic review on reporting of methodological and clinical issues in randomized controlled trials. European Journal of Cancer, 51, p S277, 2015, ECCO18 - ESMO40, European Cancer Congress, Vienna, Austria, September, 2015. DOI: 10.1016/S0959-8049(15)30037-X

 

Johnson CD, Wheelwright S, Fitzsimmons D,  Young T. Pretesting the EORTC QLQ-ELD15 in patients aged 70 years and above with a haematological malignancy. 21st Annual Conference of the International Society for Quality of Life Research, Berlin, Germany, October 2014. Qual Life Res 23, 2014.

 

Petersen MA et al. Development of the EORTC emotional functioning item bank for computer adaptive testing (CAT). 21st Annual Conference for the International Society for Quality of Life Research, Berlin, Germany, October 2014. Qual Life Res 23:1,23, 2014.

 

Rees J, Whale K, Fish D, Fayers P, Cafaro V,  Pusic A, Blazeby JM, Efficace F.  EORTC Quality of Life Group PROMOTION Registry Patient-Reported Outcomes In Randomized Controlled Trials of Colorectal Cancers. Methodological Quality and Impact on Clinical-Decision-Making 21st Annual Conference of the International Society for Quality of Life Research (ISOQOL), Berlin, Berlin (Germany). Quality of Life Research, 23(1):54-55 (abs.210.4), 2014.

 

Efficace F, Cemal Y, Pusic A ,  Fayers P, Piciocchi A, Rees J, Blazeby JM. EORTC Quality of Life Group PROMOTION Registry. Methodological Quality of Patient-Reported Outcomes (PROs) In Breast Cancer Trials According to the CONSORT PRO Extension: Evidence from 123 Trials enrolling over 83,000 patients. 21st Annual Conference of the International Society for Quality of Life Research (ISOQOL), Berlin (Germany). Quality of Life Research, 23(1):55 (abs.210.5), 2014.

 

Coens C, Greimel E, Casado A, Kristensen GB, Reed NS, Rustin G, Bottomley A, Vergote I. Institutional Quality of Life Compliance in an Advanced Ovarian Cancer Surgery Phase III Study. 21st Annual Conference of the International Society for Quality of Life Research, Berlin, Germany, abstract number 205.5, October 2014.

 

Quinten C, Ghislain I, Zikos E, Ediebah DE, Coens C, Martinelli F, Maringwa JT, Reeve BB, Ringash J, Gotay C, Greimel E, King M, Cleeland CS, Flechtner H, Schmucker-Von Koch J, Taphoorn MJB, Weis J, Velikova G, Bottomley A. Understanding the age-dependent cancer burden on pre-treated health-related quality of life of cancer patients using the EORTC QLQ-C30: A pooled analysis of randomized controlled trials. 21st Annual Conference of the International Society for Quality of Life Research, Berlin, Germany, abstract number 2010 October 2014.

 

Zikos E., Coens C., Sprangers M.A.G., Greimel E., Ghislain I., Ediebah D.E., Flechtner H., Bottomley A. on behalf of the Quality of Life Department and the EORTC Clinical Groups. Has health-related quality of life assessment in EORTC clinical trials helped to obtain regulatory approvals and change clinical practice? A review of the EORTC experience in cancer clinical trials. 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago (USA), May 30-June 3, 2014. J Clin Oncol 32:5s, 2014 (suppl; abstr 9570).

 

Ediebah D.E., Galindo-Garre F.,  Uitdehaag B.M.J., Ringash J., Reijneveld J.C., Dirven L., Zikos E., Coens C., van den Bent M.J., Bottomley A., Taphoorn M.J.B. Joint modeling of longitudinal health-related quality of life (HRQoL) data and survival. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago (USA), May 30-June 3, 2014. Chicago. J Clin Oncol 32:5s, 2014 (suppl; abstr 2034).

 

Ediebah DE, Grant W, Coens C, Quinten C, Zikos E, Reeve BB, Gotay C, Ringash J, Cleeland CS, Flechtner H, Greimel E, Velikova G, Schmucker-Von Koch J, Van Herpen CML, Vermorken JB, Taphoorn MJB, Bottomley A. Effect of completion-time windows in the analysis of health-related quality of life (HRQOL) outcomes in radiotherapy clinical trial. 21st Annual Conference of the International Society for Quality of Life Research, Berlin, Germany, abstract number 1010, October 2014.

 

Martinelli F, Fitzsimmons D, Johnson CD, Velikova G, Gronvold M, Bottomley A. Enhancing standards and ensuring good long-term use of data in quality of life research: an update on the EORTC QLG Data Repository Project. 21st Annual Conference of the International Society for Quality of Life Research, Berlin, Germany, Abstract number 2007, October 2014.

 

Kuliś D, Whittaker C, Greimel E, Bottomley A, Koller M. What does a decade matter? The evolution of translation activities in the EORTC Quality of Life Group in the past 10 years. 21st Annual Conference of the International Society for Quality of Life Research, Berlin, Germany, abstract number 2072, October 2014.

 

Wheelwright S, Fitzsimmons D, Darlington A-S, Fayers P, Arraras J Ignacio, Bonnetain F, Brain E, Bredart A, Chie W, Giesinger J, Hammerlid E, O’Connor S, Oerlemans S, Pallis A, Reed M, Singhal N, Vassiliou V, Young T, Johnson CD. Measuring Health-related Quality of Life in Elderly Patients with Cancer. British Psychosocial Oncology Society (BPOS) Annual Conference, Southampton, UK, January 2013. Psycho-Oncology 22 (Suppl. 1): 30–31 (2013).

 

Wheelwright S, Fitzsimmons D, Hopkinson J, Darlington A, Balstad T Rakel, Domeisen F, Kaasa S, Pinto M, Skeidsvoll T, Strasser F, Johnson C. Health-related quality of life in cancer patients with cachexia. British Psychosocial Oncology Society (BPOS) Annual Conference, Southampton, UK, January 2013. Psycho-Oncology 22 (Suppl. 1): 30–31 (2013).

 

Petersen MA et al. Transition from EORTC QLQ-C30 to ‘‘EORTC QLQ-CAT’’: results and experiences from the development of CAT for 10 HRQOL domains. 20th Annual Conference for the International Society for Quality of Life Research, Miami, Florida, USA, October 2013. Qual Life Res 22:1,31, 2013.

 

Rees J, Blazeby J, Pusic A, Feuerstein M, Whale K, Jacobs M, Kieffer J, Cemal Y, Fish D, Yanagawa J, Fayers P, Efficace F. EORTC Quality of Life Group PROMOTION Project. Concordance of patient reported (PROs) and clinical outcomes in randomized controlled trials (RCTs) of cancer treatment. Evidence from 192 RCTs of patients with solid tumors. 20th Annual Conference of the International Society for Quality of Life Research, Miami (FL), USA. Quality of Life Research, 22(1):13  (abs.103.2), 2013.

 

Efficace F, Feuerstein M, Pusic A, Cafaro V, Fayers P, Blazeby J. EORTC Quality of Life Group PROMOTION Project. Patient-Reported Outcomes In Randomized Controlled Trials of Genitourinary Cancers. Methodological Quality and Impact on Clinical-Decision-Making. 20th Annual Conference of the International Society for Quality of Life Research, Miami (FL), USA. Quality of Life Research, 22(1):13  (abs.103.1), 2013.

 

Leleu X, Petrucci MT, Welslau M, Vande Broek I, Murphy PT, Bottomley A, Bacon P, Lewis P, Gilet H, Arnould B, Kyriakou C. Psychometric Performance Of The EORTC Quality-Of-Life Core Questionnaire (QLQ-C30) and QLQ-Multiple Myeloma (QLQ-MY20) In Relapsed/Refractory Multiple Myeloma (RRMM). The 55th ASH Annual Meeting and Exposition, 2013, New Orleans, LA, abstract number, 1721, 7 December 2013.

 

Kulis D, Whittaker C, Greimel E, Bottomley A, Koller M. on behalf of the EORTC Quality of Life Group. New concepts for back translation review: the EORTC’s perspective. 20th Annual Conference for the International Society for Quality of Life Research, Miami, FL (USA), 9-12 October 2013. Qual Life Res 22:60, 2013.

 

Zikos E, Coens C, Sprangers MAG, Ediebah DE, Greimel E, Flechtner H, Bottomley A. on behalf of the Quality of Life Department and the EORTC Clinical Groups. A Review of Health-Related Quality of Life Assessment in EORTC Cancer Clinical Trials. 20th Annual Conference of the International Society for Quality of Life Research, Miami, Florida (USA), October 2013, Qual Life Res 22:83, 2013 (suppl; abstr 1090).

 

Ediebah DE, Reijneveld JC, Taphoorn MJB, Coens C,  Zikos E, Bottomley A, Klein M. on behalf of the VU University Medical Center, EORTC Quality of Life Department and Patient Reported Outcome and Behavioral Evidence (PROBE) Patient-proxy agreement of health-related quality of life (HRQOL) measurements in low-grade glioma patients. 20th Annual Conference of the International Society for Quality of Life Research, Miami, Florida (USA), October 2013, Qual Life Res 22:84, 2013 (suppl; abstr 1093).

 

Zikos E, Ghislain I, Ediebah DE, Quinten C, van Meerbeeck J, Stupp R, Koller M, Flechtner H, Sprangers MAG, Bottomley A. Health-Related Quality of Life in Small-Cell Lung Cancer: A Systematic Review on Reporting of Methodological and Clinical Issues in Randomized Controlled Trials. European Journal of Cancer, 49, p S270, ECCO17-ESMO38-ESTRO32 European Cancer Congress, Amsterdam, Netherlands, 27 September - 1 October 2013.

 

Ediebah DE, Reijneveld JC, Taphoorn MJB, Coens C, Zikos E,  Bottomley A, Klein M, on behalf of the VU University Medical Center, EORTC Quality of Life Department and Patient Reported Outcome and Behavioral Evidence (PROBE). Patient-proxy agreement of health-related quality of life (HRQOL) measurements in low-grade glioma patients. The European Cancer Conference, 2013, ECCO17-ESMO38-ESTRO32, Amsterdam, The Netherlands, abstract number, 1350, 27 September – 1 October 2013.

 

Bottomley A, Henrikkson R, Taphoorn M.J.B,Cloughesy T. Wick W, Mason W. Saran F. Nishikawa RRavelo, A, Chinot  O.L .Health-related quality of life (HRQoL) in AVAglio, a randomized, placebo (P)-controlled phase III study of bevacizumab (B), temozolomide (T) and radiotherapy (RT) in patients (pts) with newly diagnosed glioblastoma (GBM). The European Cancer Conference,  2013, ECCO17-ESMO38-ESTRO32, Amsterdam, The Netherlands, abstract number, 3316, page 409,  27 September – 1 October 2013.

 

Henriksson R, Bottomley A, Mason W, Saran F, Wick W, Nishikawa R, Cloughesy TF, Carpentier AF, Hoang-Xuan K, Kavan P, Cernea, D, Brandes AA, Hilton M, Guijarro AM, Ravelo A, Chinot O.  Progression-free survival (PFS) and health-related quality of life (HRQoL) in AVAglio, a phase III study of bevacizumab (Bv), temozolomide (T), and radiotherapy (RT) in newly diagnosed glioblastoma (GBM). 2013 ASCO Annual Meeting Chicargo, USA.  Journal of Clinical Oncology, Proceedings. Vol 31, 2005, No 15_suppl  (May 20 Supplement), 2013.

 

Wheelwright S, Darlington A-S, Hopkinson JB, Fitzsimmons D, White A, Johnson CD. A systematic review of the use and validation of health-related quality of life instruments in patients with cancer cachexia. 19th Annual Conference of the International Society for Quality of Life Research, Budapest, Hungary, October 2012. Qual Life Res 21, 2012.

 

Johnson CD, Wheelwright S, Fitzsimmons D,  Young T. Pretesting the EORTC QLQ-ELD15 in patients aged 70 years and above with a haematological malignancy. 19th Annual Conference of the International Society for Quality of Life Research, Budapest, Hungary, October 2012. Qual Life Res 21, 2012.

 

Wheelwright S, Darlington A-S, Hopkinson JB, Fitzsimmons D, White A, Johnson CD. A systematic review of the use and validation of health-related quality of life instruments in patients with cancer cachexia. 8th National Cancer Research Institute, Liverpool, UK, November 2012.

 

Johnson CD, Wheelwright S, Fitzsimmons D,  Young T. Pretesting the EORTC QLQ-ELD15 in patients aged 70 years and above with a haematological malignancy. 8th National Cancer Research Institute, Liverpool, UK, November 2012.

 

Habets E, Taphoorn M, Nederend S, Klein M, Delgadillo, Xuan K, Bottomley A, Allgeier A, Seute T, Gans J, Enting RH, Tijssen, Van Den Bent M, Rejiveld J. Health-related quality of life and cognitive functioning in long-term anaplastic glioma survivors from eortc study 26951. 17th Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology (SNO), November 15-18, 2012, Washington, D.C. euro Oncol (2012) 14 (suppl 6):vi153-vi159.doi: 10.1093/neuonc/nos240

 

O'connell J, Bottomley A, Ramalingam SS, Boyer M, Park K, Blackhall F,  Mundayat R, Campbell A.  Evaluation Of Symptom Impact Of Dacomitinib (Pf-00299804) Vs Erlotinib In Patients With Advanced Nsclc After Chemotherapy Failure: Results From A Phase 2 Randomized Clinical Trial.  Journal Of Thoracic Oncology, 2012.

 

O'connell J, Bottomley A, Ramalingam SS, Boyer M, Park K, Blackhall F,  Mundayat R, Campbell A Evaluation Of Symptom Impact Of Dacomitinib (Pf-00299804) Vs Erlotinib In Patients With Advanced Nsclc After Chemotherapy Failure: Results From A Phase 2 Randomized Clinical Trial." 10th Annual Meeting of the Japanese Society of Medical Oncology, 26–28 July 2012: Osaka, Japan, In Journal Of Thoracic Oncology. Volume 23 suppl 11,  6, pp. S60-S612012.

 

Soffietti R, Mueller RP, Abacioglu MU, Villa S, Fauchon F, Baumert B, Fariselli L, Tridello G, Kocher M, Bottomley A.  An EORTC Phase III trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in patients with 1 to 3 Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results.  19th Annual Conference of the International Society for Quality of Life Research, Budapest (Hungary), October 2012, Qual Life Res 21:69, 2012 (suppl; abstr 1042).

 

Zeng L, Chow E, Bedard G, Zhang L, Fairchild A, Vassiliou V, Alm El-Din MA, Jesus-Garcia R, Kumar A, Forges F, Tseng LM, Hou MF, Chie WC, Bottomley A. An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases. 19th Annual Conference of the International Society for Quality of Life Research, Budapest (Hungary), October 2012, Qual Life Res 21:69, 2012 (suppl; abstr 1099).

 

Ediebah DE, Coens C, Zikos E, Ringash J, Quinten C, Gotay C, Greimel E, Osoba D, King M, Flechtner H, Taphoorn MJ, Schmucker-Von Koch J, Weis J, Cleeland CS, Reeve BB, Smit EF, Bottomley A. on behalf of the Lung Cancer Cooperative Group, Quality of Life Department and Patient Reported Outcome and Behavioral Evidence (PROBE) Does change in health-related quality of life (HRQoL) score predict survival? Sensitivity analysis of a lung cancer RCT. 19th Annual Conference of the International Society for Quality of Life Research, Budapest (Hungary), October 2012, Qual Life Res 21:69, 2012 (suppl; abstr 1079).

 

Ediebah DE, Coens C, Zikos E, Ringash J, Quinten C, Gotay C, Greimel E, Osoba D, King M, Flechtner H, Taphoorn M J, Schmucker-Von Koch J, Weis J, Cleeland CS, Reeve BB, Smit EF, Bottomley A; on behalf of the Lung Cancer Cooperative Group, Quality of Life Department and Patient Reported Outcome and Behavioral Evidence (PROBE). Joint modeling of longitudinal health-related quality of life data and overall survival. 19th Annual Conference of the International Society for Quality of Life Research, Budapest (Hungary), October 2012, Qual Life Res 21:18, 2012 (suppl; abstr 202.1).

 

Zikos E, Ediebah DE, Coens C, Quinten C,  Ringash J, Reeve B B, Cleeland CS, Flechtner H, Gotay C, Greimel E, King M, Osoba D, Schmucker-Von Koch J,  Taphoorn M J, Weis J, Bottomley A;on behalf of the European Organisation for Research and Treatment of Cancer (EORTC) and the Patient-Reported Outcome and Behavioural Evidence (PROBE). The Added Clinical Value of Health-Related Quality of Life Research: Major Outcomes of the Pooled Analysis of Phase III Randomised Clinical Trials. 19th Annual Conference of the International Society for Quality of Life Research, Budapest (Hungary), October 2012, Qual Life Res 21:120, 2012 (suppl; abstr 3051).

 

Zikos E, Coens C, Ghislain I, Ediebah DE, Sloan E, Quinten C, Koller M, van Meerbeeck  JP, Flechtner H, Stupp R, Pallis A, Czimbalmos A, Bottomley A; on behalf of the European Organisation for Research and Treatment of Cancer. A Systematic Review in Health-Related Quality of Life Reporting in Small-Cell Lung Cancer Clinical Trials: An Examination into the Added Value of Health-Related Quality Of Life Findings. 19th Annual Conference of the International Society for Quality of Life Research, Budapest (Hungary), October 2012, Qual Life Res 21:5, 2012 (suppl; abstr 102.2).

 

Arnott M, Koller M, Greimel E, Bottomley A, Whittaker C, Kuliś D; on behalf of the EORTC Quality of Life Group. A review of the existing EORTC quality of life measures in Spanish: response scales evaluation. 19th Annual Conference for the International Society for Quality of Life Research, Budapest (Hungary), 24-27 October 2012. Qual Life Res 21:119, 2012.

 

Kuliś D, Arnott M, Whittaker C, Greimel ER, Bottomley A, Koller M; on behalf of the EORTC Quality of Life Group. Linguistic differences between translations of quality-of-life questionnaires: a comparative study of the English and Polish versions of EORTC QLQ-C30. 19th Annual Conference for the International Society for Quality of Life Research, Budapest (Hungary), 24-27 October 2012. Qual Life Res 21:58, 2012.

 

Martinelli F, Velikova G, Johnson CD, Grønvold M, Coens C, Bottomley A. Endorsing high quality standards in developing measures to assess QoL in cancer patients: the Data Repository initiative on behalf of the EORTC QLG. 19th Annual Conference for the International Society for Quality of Life Research, Budapest (Hungary), 24-27 October 2012. Qual Life Res 21:131, 2012.

 

Coens C, Van der Graaf WTA,  Blay JY,  Chawla S,  Kim DW,  Sanfilippo R,  Manson S, Ouali M, Marreaud S, Bottomley A. Results of HRQOL data from PALETTE: A randomized double bline phase III trials of Pazopanib versus placebo in metastatic soft tissue sarcomsa patients: An EORTC STBSF Global Netword Study (EORTC 6207). 34th European Society for Medical Oncology (ESMO) Congress; 204 Oct; Vienna, Austria. Annals of Oncology supplement 15(3): 123, abs. 1100.

 

Quinten C,  Zikos E, Sprangers M, Greimel E, Martinelli F,  Reeve BB, Ringash J, Gotay C, Maringwa J, Coens C, Ediebah DE,  King M, Osoba D, Cleeland CS, Flechtner H, Schmucker-Von Koch J, Taphoorn MJ, Weis J, Bjordal K, Bottomley A; on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. An international study of multi-trial data investigating quality of life and symptoms as prognostic factors for survival in different cancer sites. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago (USA), June 2012. J Clin Oncol 30: 2012 (suppl; abstr 6002)

 

Ediebah D.E., Coens C., Zikos E., Quinten C., Ringash J., Gotay C., Greimel E., Maringwa J., King M., Flechtner H., Taphoorn M. J., Schmucker-Von Koch J., Weis J., Reeve B. B., Smit E. F., Bottomley A. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. Does change in health-related quality of life (HRQoL) score predict survival? Analysis of a lung cancer RCT. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago (USA), June 2012. J Clin Oncol 30: 2012 (suppl; abstr 7607).

 

 Zikos E., Coens C., Ediebah D.E., Quinten C., Greimel E., Flechtner H., Taphoorn M. J., Reijneveld J., Koller M., Bottomley A. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. Health-related quality of life assessment in EORTC cancer clinical trials. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago (USA), June 2012. J Clin Oncol 30: 2012 (suppl; abstr 6090).

 

Quinten C.,  Zikos E., Sprangers M., Greimel E., Martinelli F.,  Reeve B. B., Ringash J., Gotay C., Maringwa J., Coens C., Ediebah D.E.,  King M., Osoba D., Cleeland C. S., Flechtner H., Schmucker-Von Koch J., Taphoorn M. J., Weis J., Bjordal K., Bottomley A. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. An international study of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different cancer sites. 48th Annual Meeting of the American Society of Clinical Oncology (ASCO), Chicago (USA), June 2012. J Clin Oncol 30: 2012 (suppl; abstr 6002).

 

Ediebah D.E., Quinten C., Coens C., Zikos E., Ringash J., Gotay C., Flechtner H., Osoba D., King M., Cleeland C. S., Greimel E., Reeve B., Taphoorn M., von Koch J. S., Weis J., Bottomley A. on the behalf of the NCIC-CTG and EORTC. Validation Study Of The Baseline Quality Of Life As A Prognostic Indicator Of Survival: A Pooled Analysis Of Individual Patient Data From NCIC Clinical Trials. International Society for Pharmaoeconomics and Outcomes Research 14th Annual European Congress 5-8th November, Madrid, Spain, CN3 234, Nov 2011. DOI: 10.1016/j.jval.2011.08.016

 

 

Ediebah D.E., Coens C., Zikos E., Gotay C., Osoba D., Quinten C., Maringwa J.T., King M., Flechtner H., Bottomley A. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. Effect of Completion-time Windows in the Analysis of Health-Related Quality of Life Outcomes. European Journal of Cancer, 47, p 232, 2011 ECCO16-ESMO36-ESTRO30 European Multidisciplinary Cancer Congress, Stockholm, Sweden, September 2011. DOI:10.1016/S0959-8049(11)71108-X

 

 

Zikos E., Coens C., Ediebah D.E., Greimel E., Reeve B.B., Ringash J., Schmucker-Von Koch J., Taphoorn M.J., Weis J., Bottomley A. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. Is There Any Added Value in the Pooled Analysis of over 120 Large Scale Phase III Randomized Clinical Trials in Health Related Quality of Life? European Journal of Cancer, 47, p 223, 2011 ECCO16-ESMO36-ESTRO30 European Multidisciplinary Cancer Congress, Stockholm, Sweden, September 2011. DOI: 10.1016/S0959-8049(11)71078-4

 

Zikos E., Sloan E.K., Ediebah D.E., Coens C., Quinten C., Koller M., van Meerbeeck J., Flechtner H., Martinelli F., Bottomley A. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. Health-Related Quality of Life in Small-Cell Lung Cancer: A Systematic Review on Methodological Issues in Randomized Controlled Trials. European Journal of Cancer, 47, p 232, 2011 ECCO16-ESMO36-ESTRO30 European Multidisciplinary Cancer Congress, Stockholm, Sweden, September 2011. DOI: 10.1016/S0959-8049(11)71107-8

 

Quinten C., Zikos E., Ediebah D.E., Coens C., Maringwa J., Martinelli F., Cleeland C. S., Flechtner H., Gotay C., Greimel E., King M., Osoba D., Taphoorn M. J., Reeve B. B., Ringash J., Schmucker-Von Koch J., Weis J., Bottomley A. on behalf of the EORTC; European Organisation for Research and Treatment of Cancer Headquarters. The Added Value of Patient Reported Outcomes in Oncology Clinical Trials: The PROBE Experience. 18th Day of Statistical Centers Against Cancer, Lille, France, Presentation, July 2011.